Long-term safety and asthma control with budesonide/ formoterol versus budesonide pressurized metered-dose inhaler in asthma patients
Keywords: Asthma; asthma control; budesonide; combination therapy; formoterol; inhaled corticosteroid; long-acting 2-adrenergic agonist; long-term safety; pressurized metered-dose inhaler; randomized controlled trial
Document Type: Research Article
Affiliations: 1: From the Section on Pulmonary and Critical Care Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina, 2: Associate Clinical Professor, School of Medicine, Allergy/Immunology, University of California, San Diego School of Medicine, San Diego, California, and 3: AstraZeneca, Drug Development, Wilmington, Delaware
Publication date: 01 September 2008
- Allergy and Asthma Proceedings is a peer reviewed publication dedicated to distributing timely scientific research regarding advancements in the knowledge and practice of allergy, asthma and immunology. Its primary readership consists of allergists and pulmonologists.
The goal of the Proceedings is to publish articles with a predominantly clinical focus which directly impact quality of care for patients with allergic disease and asthma.
Featured topics include asthma, rhinitis, sinusitis, food allergies, allergic skin diseases, diagnostic techniques, allergens, and treatment modalities. Published material includes peer-reviewed original research, clinical trials and review articles.
Articles marked "F" offer free full text for personal noncommercial use only.
The journal is indexed in Thomson Reuters Web of Science and Science Citation Index Expanded, plus the National Library of Medicine's PubMed service.
- Editorial Board
- Information for Authors
- Submit a Paper
- Information for Advertisers
- Reprint Requests
- Ingenta Connect is not responsible for the content or availability of external websites